Academic Journal
Immunoinformatics design and synthesis of a multi-epitope vaccine against Helicobacter pylori based on lipid nanoparticles.
| Τίτλος: | Immunoinformatics design and synthesis of a multi-epitope vaccine against Helicobacter pylori based on lipid nanoparticles. |
|---|---|
| Συγγραφείς: | Jebali A; Department of Medical Nanotechnology, Faculty of Advanced Sciences and Technology, Tehran Medical Science, Islamic Azad University, Tehran, Iran.; Farhikhtegan Medical Convergence Sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran., Esmaeilzadeh A; Department of Nanobiomimetics, Faculty of Advanced Sciences and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran. esmaeilzadeh2016@gmail.com., Esmaeilzadeh MK; Eeducational and Hospital Pharmacies Complex, Isfahan University of Medical Sciences, Isfahan, Iran., Shabani S; Department of Biological Sciences, Bio-molecular Science Institute, Florida International University, Miami, FL, USA. |
| Πηγή: | Scientific reports [Sci Rep] 2024 Aug 02; Vol. 14 (1), pp. 17910. Date of Electronic Publication: 2024 Aug 02. |
| Τύπος έκδοσης: | Journal Article |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: London : Nature Publishing Group, copyright 2011- |
| Ιατρικοί όροι (MeSH): | Helicobacter pylori*/immunology , Nanoparticles*/chemistry , Bacterial Vaccines*/immunology , Bacterial Vaccines*/chemistry , Computational Biology*/methods, Bacterial Proteins/immunology ; Bacterial Proteins/chemistry ; Epitopes/immunology ; Epitopes/chemistry ; Antigens, Bacterial/immunology ; Antigens, Bacterial/chemistry ; Helicobacter Infections/prevention & control ; Helicobacter Infections/immunology ; Toll-Like Receptor 4/immunology ; Urease/immunology ; Urease/chemistry ; Humans ; Molecular Docking Simulation ; Immunoinformatics ; Liposomes |
| Περίληψη: | Helicobacter pylori (H. pylori) is responsible for various chronic or acute diseases, such as stomach ulcers, dyspepsia, peptic ulcers, gastroesophageal reflux, gastritis, lymphoma, and stomach cancers. Although specific drugs are available to treat the bacterium's harmful effects, there is an urgent need to develop a preventive or therapeutic vaccine. Therefore, the current study aims to create a multi-epitope vaccine against H. pylori using lipid nanoparticles. Five epitopes from five target proteins of H. pylori, namely, Urease, CagA, HopE, SabA, and BabA, were used. Immunogenicity, MHC (Major Histocompatibility Complex) bonding, allergenicity, toxicity, physicochemical analysis, and global population coverage of the entire epitopes and final construct were carefully examined. The study involved using various bioinformatic web tools to accomplish the following tasks: modeling the three-dimensional structure of a set of epitopes and the final construct and docking them with Toll-Like Receptor 4 (TLR4). In the experimental phase, the final multi-epitope construct was synthesized using the solid phase method, and it was then enclosed in lipid nanoparticles. After synthesizing the construct, its loading, average size distribution, and nanoliposome shape were checked using Nanodrop at 280 nm, dynamic light scattering (DLS), and atomic force microscope (AFM). The designed vaccine has been confirmed to be non-toxic and anti-allergic. It can bind with different MHC alleles at a rate of 99.05%. The construct loading was determined to be about 91%, with an average size of 54 nm. Spherical shapes were also observed in the AFM images. Further laboratory tests are necessary to confirm the safety and immunogenicity of the multi-epitope vaccine. (© 2024. The Author(s).) |
| References: | Nat Rev Dis Primers. 2023 Apr 20;9(1):19. (PMID: 37081005) Vaccine. 2019 Nov 28;37(50):7295-7299. (PMID: 29627231) Appl Microbiol Biotechnol. 2014 Apr;98(8):3495-507. (PMID: 24370888) Cell Mol Immunol. 2020 Jan;17(1):50-63. (PMID: 31804619) Mol Biosyst. 2017 Mar 28;13(4):699-713. (PMID: 28194462) Sci Rep. 2019 Sep 16;9(1):13321. (PMID: 31527719) Expert Rev Vaccines. 2021 Aug;20(8):989-999. (PMID: 34139141) Pathogens. 2023 Feb 25;12(3):. (PMID: 36986298) J Immunol Methods. 2022 Sep;508:113325. (PMID: 35908655) J Comput Biol. 2019 Oct;26(10):1177-1190. (PMID: 31120321) Int J Pept Res Ther. 2021;27(2):1149-1166. (PMID: 33495694) Helicobacter. 2020 Sep;25 Suppl 1:e12736. (PMID: 32918351) Toxins (Basel). 2021 Jul 13;13(7):. (PMID: 34357957) Eur J Clin Microbiol Infect Dis. 2020 Oct;39(10):1821-1830. (PMID: 32557327) Mediators Inflamm. 2014;2014:426309. (PMID: 24587595) Gastroenterology. 1997 Dec;113(6 Suppl):S31-4; discussion S50. (PMID: 9394757) Microb Pathog. 2021 Aug;157:104970. (PMID: 34022362) Immunol Res. 2023 Aug;71(4):639-662. (PMID: 37022613) Infect Genet Evol. 2017 Apr;49:309-317. (PMID: 28185986) Pathog Dis. 2015 Jul;73(5):. (PMID: 25846576) Helicobacter. 2022 Jun;27(3):e12886. (PMID: 35343031) Expert Rev Vaccines. 2022 Apr;21(4):569-587. (PMID: 34932430) Genomics. 2020 Sep;112(5):3473-3483. (PMID: 32562830) World J Gastroenterol. 2018 Aug 7;24(29):3204-3221. (PMID: 30090002) Mol Divers. 2023 Oct 6;:. (PMID: 37801217) Vaccine. 2009 Aug 6;27(36):5013-9. (PMID: 19446591) J Mol Recognit. 2016 Jun;29(6):266-75. (PMID: 26748949) Int J Pept Res Ther. 2021;27(2):1027-1042. (PMID: 33424523) FASEB J. 2022 Apr;36(4):e22252. (PMID: 35294065) Helicobacter. 2017 Dec;22(6):. (PMID: 28851031) Int J Clin Exp Pathol. 2014 Sep 15;7(10):6559-66. (PMID: 25400734) Int J Mol Sci. 2022 Mar 13;23(6):. (PMID: 35328512) Gut Pathog. 2022 May 27;14(1):21. (PMID: 35624464) |
| Contributed Indexing: | Keywords: Helicobacter pylori; Immunoinformatics; Multi-epitope; Vaccine |
| Substance Nomenclature: | 0 (Bacterial Vaccines) 0 (Lipid Nanoparticles) 0 (Bacterial Proteins) 0 (Epitopes) 0 (Antigens, Bacterial) 0 (Toll-Like Receptor 4) 0 (cagA protein, Helicobacter pylori) EC 3.5.1.5 (Urease) 0 (Liposomes) |
| Entry Date(s): | Date Created: 20240802 Date Completed: 20240802 Latest Revision: 20240808 |
| Update Code: | 20260130 |
| PubMed Central ID: | PMC11297249 |
| DOI: | 10.1038/s41598-024-68947-x |
| PMID: | 39095538 |
| Βάση Δεδομένων: | MEDLINE |
| ISSN: | 2045-2322 |
|---|---|
| DOI: | 10.1038/s41598-024-68947-x |